Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
METIPRENALINE
ID: ALA2074647
Max Phase: Phase
Molecular Formula: C12H19NO3
Molecular Weight: 225.29
Molecule Type: Small molecule
Associated Items:
ID: ALA2074647
Max Phase: Phase
Molecular Formula: C12H19NO3
Molecular Weight: 225.29
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: COc1cc(C(O)CNC(C)C)ccc1O
Standard InChI: InChI=1S/C12H19NO3/c1-8(2)13-7-11(15)9-4-5-10(14)12(6-9)16-3/h4-6,8,11,13-15H,7H2,1-3H3
Standard InChI Key: XXCCGRRUBBGZRE-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 225.29 | Molecular Weight (Monoisotopic): 225.1365 | AlogP: 1.43 | #Rotatable Bonds: 5 |
Polar Surface Area: 61.72 | Molecular Species: BASE | HBA: 4 | HBD: 3 |
#RO5 Violations: 0 | HBA (Lipinski): 4 | HBD (Lipinski): 3 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 10.11 | CX Basic pKa: 9.36 | CX LogP: 0.74 | CX LogD: -0.90 |
Aromatic Rings: 1 | Heavy Atoms: 16 | QED Weighted: 0.71 | Np Likeness Score: 0.37 |
1. Martel F, Vetter T, Russ H, Gründemann D, Azevedo I, Koepsell H, Schömig E.. (1996) Transport of small organic cations in the rat liver. The role of the organic cation transporter OCT1., 354 (1): [PMID:8878062] [10.1007/bf00171063] |
2. Gründemann D, Gorboulev V, Gambaryan S, Veyhl M, Koepsell H.. (1994) Drug excretion mediated by a new prototype of polyspecific transporter., 372 (1): [PMID:7990927] [10.1038/372549a0] |
3. Gorboulev V, Ulzheimer JC, Akhoundova A, Ulzheimer-Teuber I, Karbach U, Quester S, Baumann C, Lang F, Busch AE, Koepsell H.. (1997) Cloning and characterization of two human polyspecific organic cation transporters., 16 (1): [PMID:9260930] [10.1089/dna.1997.16.871] |
4. Gründemann D, Köster S, Kiefer N, Breidert T, Engelhardt M, Spitzenberger F, Obermüller N, Schömig E.. (1998) Transport of monoamine transmitters by the organic cation transporter type 2, OCT2., 273 (1): [PMID:9812985] [10.1074/jbc.273.47.30915] |
5. Arndt P, Volk C, Gorboulev V, Budiman T, Popp C, Ulzheimer-Teuber I, Akhoundova A, Koppatz S, Bamberg E, Nagel G, Koepsell H.. (2001) Interaction of cations, anions, and weak base quinine with rat renal cation transporter rOCT2 compared with rOCT1., 281 (1): [PMID:11502595] [10.1152/ajprenal.2001.281.3.f454] |
6. Hayer-Zillgen M, Brüss M, Bönisch H.. (2002) Expression and pharmacological profile of the human organic cation transporters hOCT1, hOCT2 and hOCT3., 136 (1): [PMID:12110607] [10.1038/sj.bjp.0704785] |
7. USP Dictionary of USAN and International Names (2010 edition) and USAN registrations 2007-date, |
Source(2):